RAD 202 receives approval to start Phase 1 therapeutic trial

0 Min Read December 20, 2024

Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial

Download the PDF here.

This post appeared first on investingnews.com

    Join Our Newsletter

    Stay updated every week with our latest articles, series, and posts